Mark DiPaolo

CIK 1669816 · last filed 2026-05-06

Mark DiPaolo is a corporate insider who has filed 15 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for INVA, was dated May 6, 2026. Current disclosed insider exposure totals $3.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.20M

Companies

3

Total Filings

15

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INVA Director 140,492 $22.74 $3.19M $0 10 2026-05-06
AMRN Director 401 $15.24 $6.1K $0 3 2025-04-22
NOVELION THERAPEUTICS INC. (NVLN) Delisted Director $0 2 2018-08-13

Recent Filings

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-05-06 INVA Grant (A) +9,786 $0 EDGAR
2025-05-21 INVA Grant (A) +12,077 $0 EDGAR
2025-04-22 AMRN Mixed +401 -$4.0K EDGAR
2024-06-20 INVA Grant (A) +13,923 $0 EDGAR
2024-04-19 AMRN Grant (A) $0 EDGAR
2023-07-21 AMRN Grant (A) $0 EDGAR
2023-05-24 INVA Grant (A) +16,495 $0 EDGAR
2022-04-27 INVA Grant (A) +12,647 $0 EDGAR
2021-05-20 INVA Grant (A) +17,482 $0 EDGAR
2020-04-28 INVA Grant (A) +16,917 $0 EDGAR
Showing 110 of 15
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.